Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CYP2A13 anticorps (C-Term)

CYP2A13 Reactivité: Humain WB, IHC (p), FACS Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN5534028
  • Antigène Voir toutes CYP2A13 Anticorps
    CYP2A13 (Cytochrome P450, Family 2, Subfamily A, Polypeptide 13 (CYP2A13))
    Épitope
    • 15
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 446-477, C-Term
    Reactivité
    • 37
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 35
    • 2
    Lapin
    Clonalité
    • 37
    Polyclonal
    Conjugué
    • 20
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CYP2A13 est non-conjugé
    Application
    • 33
    • 13
    • 13
    • 11
    • 7
    • 6
    • 6
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)
    Purification
    This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis
    Immunogène
    This CYP2A13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 446-477 amino acids from the C-terminal region of human CYP2A13.
    Isotype
    Ig Fraction
    Top Product
    Discover our top product CYP2A13 Anticorps primaire
  • Indications d'application
    For WB starting dilution is: 1:1000

    For IHC-P starting dilution is: 1:50~100

    For FACS starting dilution is: 1:10~50
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    2 mg/mL
    Buffer
    Supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
  • Antigène
    CYP2A13 (Cytochrome P450, Family 2, Subfamily A, Polypeptide 13 (CYP2A13))
    Autre désignation
    CYP2A13 (CYP2A13 Produits)
    Synonymes
    anticorps CPAD, anticorps CYP2A, anticorps CYPIIA13, anticorps MGC86391, anticorps MGC88881, anticorps CYP2A13, anticorps CYP2A6, anticorps cytochrome P450 family 2 subfamily A member 13, anticorps cytochrome P450, family 2, subfamily A, polypeptide 13, anticorps cytochrome P450 family 2 subfamily A member 13 L homeolog, anticorps cytochrome P450 family 2 subfamily A polypeptide 13, anticorps cytochrome P450 2A13, anticorps CYP2A13, anticorps cyp2a13.L, anticorps cyp2a13, anticorps LOC540707
    Sujet
    CYP2A13 is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. Although its endogenous substrate has not been determined, it is known to metabolize 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a major nitrosamine specific to tobacco.
    Poids moléculaire
    57 kDa
    ID gène
    1553
    UniProt
    Q16696
Vous êtes ici:
Support technique